Find verified Brepocitinib API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Brepocitinib for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Brepocitinib API.
Alternate Names: Methanone, ((1S)-2,2-difluorocyclopropyl)(3-(2-((1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-3,8-diazabicyclo(3.2.1)oct-8-yl)-, TYK2/JAK1 Inhibitor PF-06700841
CAS No: 1883299-62-4
PubChem CID: 118878093
Mol Formula: C18H21F2N7O
Mol Weight: 389.4 g/mol
IUPAC Name: [(1S)-2,2-difluorocyclopropyl]-[(1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone
Drug Class: JAK inhibitors
Source / Manufacturing Origin: Synthetic APIs
API Description: Brepocitinib is an orally available, selective inhibitor of non-receptor tyrosine-protein kinase TYK2 (tyrosine kinase 2) and tyrosine-protein kinase JAK1 (Janus kinase 1; JAK1) with potential immunomodulatory and anti-inflammatory activities. Upon oral administration, brepocitinib selectively binds to and inhibits the activation of TYK2 and JAK1, thereby disrupting TYK2 and JAK-1-dependent cytokine signaling.
